Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

Stopped early

Conditions studied: Non-Hodgkin's Lymphoma

In brief

A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the "gold standard" FDG-PET.

Key facts

Study ID

NCT00775957

Run by

University of Oklahoma

People needed

35

Starts

2008-10-01

Last updated by the study team

2010-09-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• Women must not be pregnant or breast feeding
• Histologic diagnosis of non-Hodgkin's lymphoma (any stage)
• Must undergo treatment with chemotherapy and/or radiotherapy

You may not qualify if…

• May not have received previous therapy with radiopharmaceuticals
• May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal antibodies

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.